To evaluate whether decreased ex vivo IFN-γ production is a characteristic finding in SLE, we compared ex vivo IFN-γ production between patients with SLE, patients with RA, and healthy controls. The gene discussed is IFNG; the disease is systemic lupus erythematosus.